The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Journal Volume
74
Journal Issue
8
Pages
1459-1467
Date Issued
2022
Author(s)
Boutry C.
Hastie A.
Diez-Domingo J.
Tinoco J.C.
Andrews C.
Beytout J.
Caso C.
Cheng H.-S.
Cheong H.J.
Choo E.J.
Curiac D.
Di Paolo E.
Dionne M.
Eckermann T.
Esen M.
Ferguson M.
Ghesquiere W.
Hwang S.-J.
Avelino-Silva T.J.
Kosina P.
Liu C.-S.
Markkula J.
Moeckesch B.
Murta de Oliveira C.
Park D.W.
Pauksens K.
Pirrotta P.
Plassmann G.
Pretswell C.
Rombo L.
Salaun B.
Sanmartin Berglund J.
Schenkenberger I.
Schwarz T.
Shi M.
Ukkonen B.
Zahaf T.
Zerbini C.
Schuind A.
Cunningham A.L.
Zoster-049 Study Group
SDGs
Publisher
NLM (Medline)
Type
journal article